Effects of Livagen peptide on chromatin activation in lymphocytes from old people.
Lab research · 2002
- What was studied
- Cultured lymphocytes from older donors
- Main finding
- Livagen altered chromatin organization and ribosomal-gene activity in donor-derived lymphocytes.
Study data at a glance
- Participants or experimental model
- Cultured lymphocytes from older donors
- Reported results
- Livagen altered chromatin organization and ribosomal-gene activity in donor-derived lymphocytes.
Study limitations and source details
Study limitations
- Cells from human donors are not a human treatment trial; rejuvenation and liver benefit were not established.
- Full methods, reporting completeness and independent replication remain to be appraised.
Source details
Original journal report
Primary citation and indexed abstract reviewed through Europe PMC. Full article not appraised.
Abstract reviewed
Sources checked
Citation
Author affiliations · St. Petersburg Institute of Bioregulation and Gerontology
Khavinson VKh, Lezhava TA, Monaselidze JG, Dzhokhadze TA, Dvalishvili NA, Bablishvili NK, Ryadnova IY. Effects of Livagen peptide on chromatin activation in lymphocytes from old people. Bulletin of experimental biology and medicine · PMID 12533768
Study source ↗ · DOI 10.1023/a:1021924702103 · Bibliography entry · Link to this summary